AstraZeneca may have included outdated info from US vaccine trial – NIAID – The Jerusalem Post

“The DSMB revealed concern that AstraZeneca might have included out-of-date information from that trial, which might have offered an incomplete view of the efficacy information,” the U.S. agency said, referring to the independent Data Safety Monitoring Board (DSMB).”We prompt the business to work with the DSMB to review the effectiveness data and ensure the most accurate, up-to-date effectiveness data be made public as quickly as possible.”The demand cast doubts over the businesss plan to look for U.S. emergency situation usage authorization for the vaccine in the coming weeks.Authorization and standards for usage of the vaccine in the United States will be figured out by the Food and Drug Administration and Centers for Disease Control and Prevention after extensive review of the information by independent advisory committees, stated the NIAID, part of the National Institutes of Health.AstraZeneca did not instantly respond to a Reuters request for comment.